Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

With uncertainty roiling Big Pharma, execs are placing lower-risk bets
Pharma Voice
Friday, February 7, 2025 - 11:16am
tags:
Big Pharma, JNJ, AbbVie, Novartis, Merck, Pfizer, earnings
Merck commences Phase III trial of DLBCL treatment
Clinical Trials Arena
Friday, February 7, 2025 - 11:14am
tags:
Merck, clinical trials, DLBCL, zilovertamab vedotin
Bristol Myers backs out of Dupixent fight, axing allergy asset despite phase 3 win
Fierce Biotech
Friday, February 7, 2025 - 11:11am
tags:
Bristol Myers Squibb, Dupixent, cendakimab
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Clinical Trials Arena
Friday, February 7, 2025 - 11:10am
tags:
Roche, Genentech, clinical trials, lupus, Gazyva, FDA
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
Pharmaphorum
Friday, February 7, 2025 - 11:05am
tags:
Bain Capital, M&A, Mitsubishi Tanabe Pharma
FDA starts review of first bronchiectasis drug candidate
Pharmaphorum
Friday, February 7, 2025 - 11:03am
tags:
FDA, Insmed, brensocatib, bronchiectasis
Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect
Fierce Biotech
Friday, February 7, 2025 - 11:02am
tags:
Novo Nordisk, hemophilia A, Mim8, pediatric
Vertex challenger Sionna prices $191M IPO
BioPharma Dive
Thursday, February 6, 2025 - 10:52pm
tags:
Sionna Therapeutics, IPOs, cystic fibrosis
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Fierce Pharma
Thursday, February 6, 2025 - 10:50pm
tags:
Regeneron, Sanofi, Dupixent, legal
Walgreens sells more shares in Cencora; cuts stake to 6%
Investing.com
Thursday, February 6, 2025 - 10:47pm
tags:
Walgreens Boots Alliance, Cencora
Glucotrack hits trial success for direct blood measuring CGM
Clinical Trials Arena
Thursday, February 6, 2025 - 10:43pm
tags:
Medtech, Glucotrack, CGMs, diabetes
Eli Lilly’s earnings, shares lifted by obesity drug sales
BioPharma Dive
Thursday, February 6, 2025 - 10:40pm
tags:
Eli Lilly, earnings
Bristol Myers Squibb Tops Q4 Estimates
Motley Fool
Thursday, February 6, 2025 - 11:52am
tags:
Bristol Myers Squibb, earnings
AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance
Investors Business Daily
Thursday, February 6, 2025 - 11:51am
tags:
AstraZeneca, earnings
X4 lays off 30% of staff, halts preclinical R&D to focus on Xolremdi rollout
Fierce Biotech
Thursday, February 6, 2025 - 11:45am
tags:
X4 Pharmaceuticals, R&D, mavorixafor, layoffs
With recent launches and more to come, Amgen's biosimilar business is trending up
Fierce Pharma
Thursday, February 6, 2025 - 11:43am
tags:
Amgen, biosimilars
Opioid Use Disorder Market Size Projected to Hit USD 9.02 Billion by 2032
Yahoo Finance
Thursday, February 6, 2025 - 11:42am
tags:
opioids, opioid use disorder
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Yahoo/Reuters
Thursday, February 6, 2025 - 11:40am
tags:
Novo Nordisk, tariffs, Europe, Donald Trump
Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says
The Independent, UK
Thursday, February 6, 2025 - 11:39am
tags:
Pfizer, Albert Bourla, Robert F Kennedy Jr., HHS, vaccines
Pfizer taps a former Novartis exec to lead cancer drug push
BioPharma Dive
Thursday, February 6, 2025 - 11:38am
tags:
Pfizer, Novartis, oncology, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.